Editorial commentary: meeting a paramount challenge

Ping Yang¹

Affiliations

Editorial

Ping Yang. Transl Lung Cancer Res. 2018 Apr.

. 2018 Apr;7(Suppl 2):S158-S159.

doi: 10.21037/tlcr.2018.03.17.

Ping Yang¹

¹ Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Probability of cancer in high-risk patients predicted by the protein-based lung cancer biomarker panel in China: LCBP study.
Yang D, Zhang X, Powell CA, Ni J, Wang B, Zhang J, Zhang Y, Wang L, Xu Z, Zhang L, Wu G, Song Y, Tian W, Hu JA, Zhang Y, Hu J, Hong Q, Song Y, Zhou J, Bai C. Yang D, et al. Cancer. 2018 Jan 15;124(2):262-270. doi: 10.1002/cncr.31020. Epub 2017 Sep 20. Cancer. 2018. PMID: 28940455

1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016;388:1545-602. 10.1016/S0140-6736(16)31678-6 - DOI - PMC - PubMed
1. Wong MC, Lao XQ, Ho KF, et al. Incidence and mortality of lung cancer: global trends and association with socioeconomic status. Sci Rep 2017;7:14300. 10.1038/s41598-017-14513-7 - DOI - PMC - PubMed
1. Jha P, Peto R. Global effects of smoking, of quitting, and of taxing tobacco. N Engl J Med 2014;370:60-8. 10.1056/NEJMra1308383 - DOI - PubMed
1. US-SEER 2018. Available online: https://seer.cancer.gov/report_to_nation/mortality.html
1. Moyer VA, U.S. Preventive Services Task Force Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2014;160:330-8. - PubMed